ZETAGEN THERAPEUTICS, INC. research brief

CIK 1730728 Copy CIK

Generated Nov. 8, 2026, 9:11 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: SYRACUSE NY. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

• Nov. 12, 2025 · D/A · 0001730728-25-000003 · Source evidence

  Reported offering amount: 12999998 USD. Reported amount sold: 12908022 USD.

• Jan. 23, 2025 · D · 0001730728-25-000001 · Source evidence

  Reported offering amount: 6173828 USD. Reported amount sold: 83186 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “ZETAGEN THERAPEUTICS, INC. research brief,” CIK 1730728, retrieved Nov. 8, 2026, 9:11 a.m.. Cite the specific accessions used. No amounts have been summed.